Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 03-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,342 | N/A | 39,769 | N/A | 0 |
| Receivables | 67 | N/A | 94 | N/A | 0 |
| TOTAL | $35,409 | $N/A | $39,863 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 775 | N/A | 18 | N/A | N/A |
| TOTAL | $775 | $N/A | $18 | $N/A | $N/A |
| Total Assets | $36,184 | $N/A | $39,881 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,565 | 0 | 1,498 | 0 | 0 |
| TOTAL | $2,565 | $N/A | $1,498 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 368 | 0 | 430 | 0 | 0 |
| TOTAL | $368 | $N/A | $430 | $N/A | $N/A |
| Total Liabilities | $2,933 | $N/A | $1,928 | $N/A | $0 |
| Shareholders' Equity | |||||
| Common Shares | 32 | N/A | 32 | N/A | 0 |
| Retained earnings | -34,766 | N/A | -29,803 | N/A | 0 |
| TOTAL | $33,251 | $N/A | $37,953 | $N/A | $0 |
| Total Liabilities And Equity | $36,184 | $0 | $39,881 | $0 | $0 |